Overall, our previous and current findings demonstrate essential functions for MLK3 in ovarian cancer cell proliferation, invasion, and cell cycle progression and suggest that inhibition of MLK3 activity could be a potential therapeutic approach for the treatment of ovarian cancer. Here, MAP3K11 is linked to ovarian cancer.